BHE received a $78 million minority growth investment led by Silversmith Capital Partners (Silversmith) and Leerink Transformation Partners (LTP), the company announced last week.
According to a press release, the funding will go toward bolstering BHE’s Instant Health Data (IHD) platform, a real-world evidence analytics solution utilized by more than two dozen life science and research organizations.
“We couldn’t be more thrilled to partner with the Silversmith and LTP teams,” BHE Founder and CEO Joseph Menzin said in a statement. “This new investment will allow us to double down and expand the use of our IHD platform by life science companies, as well as tap new market segments such as payers, provider organizations, and employer groups, who continue to move toward value-based care.”
To learn more about BHE, click here.